Events
Harnessing the Potential of Antibody Drug Conjugates in Oncology
Join us for Harnessing the Potential of Antibody Drug Conjugates (ADCs) in Oncology, on October 25 at Johnson & Johnson Innovation – JLABS @ Washington, DC. We’ll host oncology thoughts leaders from across the industry, Johnson & Johnson Innovation, and Janssen R&D as they dig deeper on how ADCs have become a promising cancer treatment …